Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Simone Rossi
Observed name:
Rossi, Simone
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto delle Scienze Neurologiche di Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto delle Scienze Neurologiche di Bologna,
University of Bologna
ORCID:
0000-0001-7044-983X
Observed ORCID:
0000-0001-7044-983X
OpenAlex ID:
A5002459660
Peripheral nervous system adverse events associated with immune checkpoint inhibitors
2023
·
Simone Rossi
, Francesco Gelsomino
, et al.
·
Journal of Neurology
·
70
PDF
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians
2023
·
Emanuel Raschi
, Simone Rossi
, et al.
·
Drug Safety
·
49
Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine
2021
·
Luca Baldelli
, Giulia Amore
, et al.
·
Journal of Neuroimmunology
·
43
PDF
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities
2024
·
Simone Rossi
, Antonio Farina
, et al.
·
Neurology Neuroimmunology & Neuroinflammation
·
39
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study
2023
·
Umberto Pensato
, Giulia Amore
, et al.
·
Journal of Neurology
·
24
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota
2025
·
Alberto Vogrig
, Marta Dentoni
, et al.
·
Frontiers in Immunology
·
23
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature
2022
·
Simone Rossi
, Michele Romoli
, et al.
·
Neurological Sciences
·
18
PDF
EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy
2025
·
Federica Pondrelli
, Lorenzo Muccioli
, et al.
·
Journal of Neurology
·
11
PDF
Hands–feet wireless devices: Test–retest reliability and discriminant validity of motor measures in Parkinson's disease telemonitoring
2022
·
Carlo Maremmani
, Erika Rovini
, et al.
·
Acta Neurologica Scandinavica
·
8
PDF
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
2022
·
Simone Rossi
, Ilaria Cani
, et al.
·
Journal of Clinical Oncology
·
7
PDF
Neurological adverse events of immune checkpoint inhibitors: A practical guide to diagnosis with a focus on neuroimaging findings
2025
·
Simone Rossi
, Alberto Vogrig
, et al.
·
Journal of Neuroimmunology
·
6
Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected Myasthenia Gravis: A Multicenter CBA Comparison
2026
·
Ilaria Gligora
, Pietro Businaro
, et al.
·
Neurology Neuroimmunology & Neuroinflammation
·
5
Onset of narcolepsy type 1 in a paraneoplastic encephalitis associated with a thymic seminoma
2021
·
Simone Rossi
, Gian Maria Asioli
, et al.
·
Journal of Clinical Sleep Medicine
·
5
PDF
Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities
2025
·
Simone Rossi
, Elisa Andrini
, et al.
·
Frontiers in Immunology
·
4
PDF
Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy
2025
·
Letizia Baldini
, Lucia Del Vecchio
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Comparative Study of Sporadic and Immune Checkpoint Inhibitor–Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome
2026
·
Antonio Lauletta
, Elena Rossini
, et al.
·
Neurology
·
2
Tacrolimus-associated neurotoxicity isolated to the brainstem: two illustrative cases and a systematic review of the literature
2024
·
Simone Rossi
, Rita Rinaldi
, et al.
·
Neurological Sciences
·
2
Accuracy of Antibody Testing in Myasthenia Gravis: The ADAM Study
2026
·
Maria Pia Giannoccaro
, Lucrezia Serra
, et al.
·
Neurology
·
1
Posterior Reversible Encephalopathy Syndrome with Angiogenesis Inhibitors for Solid Tumours: Clues from a Disproportionality Analysis of the FDA Adverse Event Reporting System and Pharmacodynamics
2026
·
Monia Donati
, Chiara Cancellerini
, et al.
·
Targeted Oncology
·
1
PDF
11O A comparative study of sporadic and immune checkpoint inhibitor-related forms of myasthenia gravis-myositis (MG-IM) overlap syndrome
2026
·
Antonio Lauletta
, Elena Rossini
, et al.
·
Neuromuscular Disorders
Primary Sjogren syndrome with suspected central nervous system inflammatory involvement
2026
·
Valentina Barone
, Giacomo Urbinati
, et al.
·
Neurological Sciences
Clinical, Instrumental, and Prognostic Definitions of de novo Central Nervous System Demyelinating Disorders Following Immune Checkpoint Inhibitor Therapy (P6-2.001)
2026
·
stefano Masciocchi
, Antonio Malvaso
, et al.
·
Neurology
Neuroradiological Findings in Neurological Adverse Events of CAR T therapy
2026
·
Federica Pondrelli
, Simone Rossi
, et al.
·
Springer eBooks
Reversible cerebral venous dilatation syndrome associated to cannabis consumption: Expanding the spectrum of cerebrovascular dysregulation disorders?
2022
·
Simone Rossi
, Gian Maria Asioli
, et al.
·
Neurological Sciences
Show more works
View as search
Works count:
25
Citation count:
321
H-index:
8
I10-index:
8
Year
Topic
Type